dreadd Search Results


94
MedChemExpress dreadd agonist 21
Dreadd Agonist 21, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dreadd/DREADD+agonist+21/pmc13328667-44-0-3
Average 94 stars, based on 1 article reviews
dreadd agonist 21 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Bio-Techne corporation dreadd agonist 21 dihydrochloride
Dreadd Agonist 21 Dihydrochloride, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dreadd/DREADD+agonist+21+dihydrochloride/custom%406422%4036385662
Average 94 stars, based on 1 article reviews
dreadd agonist 21 dihydrochloride - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

c21  (Tocris)
94
Tocris c21
C21, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dreadd/DREADD+agonist+21+dihydrochloride/pm38588768-137-12-20
Average 94 stars, based on 1 article reviews
c21 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
Tocris recombinant proteins compound 21 tocris
KEY RESOURCES TABLE
Recombinant Proteins Compound 21 Tocris, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dreadd/DREADD+agonist+21/pmc10529429-717-104-108
Average 95 stars, based on 1 article reviews
recombinant proteins compound 21 tocris - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
Addgene inc aavs1 pur cag bi dreadd
KEY RESOURCES TABLE
Aavs1 Pur Cag Bi Dreadd, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dreadd/AAVS1-pur-CAG-Bi-DREADD+(Plasmid+%23159457)/pm40796049-65-56-57
Average 93 stars, based on 1 article reviews
aavs1 pur cag bi dreadd - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
MedChemExpress c21
(A) Experimental scheme showing rectal AKP transplantation into Lepr-Cre(+);Chrm3 fl/fl and control mice. IVIS, in vivo imaging. (B and C) Mouse survival (B) and tumor-derived luciferase signals (C). n=6 ( Lepr-Cre(−);Chrm3 fl/fl ) and 9 mice ( Lepr-Cre(+);Chrm3 fl/fl ). (D) Non-phosphorylated YAP/PDGFRA co-IF. Red arrowheads; non-phosphorylated (active) YAP in PDGFRA + CAFs. cKO, conditional KO. n=5 mice. (E) NTN1/PDGFRA co-IF. n=5 mice. (F) VAChT IHC. Red arrowheads; VAChT + nerves. n=5 mice. (G) Experimental scheme showing rectal AKP transplantation with daily intratumor injection of the hM3Dq agonist <t>C21</t> (0.03 mg/kg) from Day 8. (H and I) Mouse survival (H) and tumor-derived luciferase signals (I). n=8 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 fl/fl ), and 7 mice ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl ). (J) Non-phosphorylated YAP/PDGFRA co-IF. Red/purple arrowheads; non-phosphorylated YAP in PDGFRA + CAFs in the Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl groups. n=4 mice. (K) NTN1/PDGFRA co-IF. n=4 mice. (L) VAChT IHC. Green/red arrowheads:VAChT + nerves in the Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT groups. n=4 mice. Scale bars, 100 μm (A and G), 50/5 μm (main/insets; D, E, J, and K), 50 μm (F and L). Log-rank test (B and H), two-way repeated-measures ANOVA with post-hoc Sidak’s multiple comparison test at week 2 (C and I), two-tailed unpaired Student’s t-test (D-F), and two-way ANOVA followed by Tukey’s post-hoc multiple comparison tests (J-L). Mean±s.e.m. (C-F and I-L). See also Figures S5 .
C21, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dreadd/DREADD+agonist+21+dihydrochloride/pmc13674685-618-11-15
Average 94 stars, based on 1 article reviews
c21 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
Tocris dreadd agonist c21
(A) Experimental scheme showing rectal AKP transplantation into Lepr-Cre(+);Chrm3 fl/fl and control mice. IVIS, in vivo imaging. (B and C) Mouse survival (B) and tumor-derived luciferase signals (C). n=6 ( Lepr-Cre(−);Chrm3 fl/fl ) and 9 mice ( Lepr-Cre(+);Chrm3 fl/fl ). (D) Non-phosphorylated YAP/PDGFRA co-IF. Red arrowheads; non-phosphorylated (active) YAP in PDGFRA + CAFs. cKO, conditional KO. n=5 mice. (E) NTN1/PDGFRA co-IF. n=5 mice. (F) VAChT IHC. Red arrowheads; VAChT + nerves. n=5 mice. (G) Experimental scheme showing rectal AKP transplantation with daily intratumor injection of the hM3Dq agonist <t>C21</t> (0.03 mg/kg) from Day 8. (H and I) Mouse survival (H) and tumor-derived luciferase signals (I). n=8 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 fl/fl ), and 7 mice ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl ). (J) Non-phosphorylated YAP/PDGFRA co-IF. Red/purple arrowheads; non-phosphorylated YAP in PDGFRA + CAFs in the Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl groups. n=4 mice. (K) NTN1/PDGFRA co-IF. n=4 mice. (L) VAChT IHC. Green/red arrowheads:VAChT + nerves in the Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT groups. n=4 mice. Scale bars, 100 μm (A and G), 50/5 μm (main/insets; D, E, J, and K), 50 μm (F and L). Log-rank test (B and H), two-way repeated-measures ANOVA with post-hoc Sidak’s multiple comparison test at week 2 (C and I), two-tailed unpaired Student’s t-test (D-F), and two-way ANOVA followed by Tukey’s post-hoc multiple comparison tests (J-L). Mean±s.e.m. (C-F and I-L). See also Figures S5 .
Dreadd Agonist C21, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dreadd/DREADD+agonist+21/pm36152627-903-13-21
Average 95 stars, based on 1 article reviews
dreadd agonist c21 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

90
Nagai Nori USA INC dreadd actuator dcz
(A) Experimental scheme showing rectal AKP transplantation into Lepr-Cre(+);Chrm3 fl/fl and control mice. IVIS, in vivo imaging. (B and C) Mouse survival (B) and tumor-derived luciferase signals (C). n=6 ( Lepr-Cre(−);Chrm3 fl/fl ) and 9 mice ( Lepr-Cre(+);Chrm3 fl/fl ). (D) Non-phosphorylated YAP/PDGFRA co-IF. Red arrowheads; non-phosphorylated (active) YAP in PDGFRA + CAFs. cKO, conditional KO. n=5 mice. (E) NTN1/PDGFRA co-IF. n=5 mice. (F) VAChT IHC. Red arrowheads; VAChT + nerves. n=5 mice. (G) Experimental scheme showing rectal AKP transplantation with daily intratumor injection of the hM3Dq agonist <t>C21</t> (0.03 mg/kg) from Day 8. (H and I) Mouse survival (H) and tumor-derived luciferase signals (I). n=8 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 fl/fl ), and 7 mice ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl ). (J) Non-phosphorylated YAP/PDGFRA co-IF. Red/purple arrowheads; non-phosphorylated YAP in PDGFRA + CAFs in the Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl groups. n=4 mice. (K) NTN1/PDGFRA co-IF. n=4 mice. (L) VAChT IHC. Green/red arrowheads:VAChT + nerves in the Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT groups. n=4 mice. Scale bars, 100 μm (A and G), 50/5 μm (main/insets; D, E, J, and K), 50 μm (F and L). Log-rank test (B and H), two-way repeated-measures ANOVA with post-hoc Sidak’s multiple comparison test at week 2 (C and I), two-tailed unpaired Student’s t-test (D-F), and two-way ANOVA followed by Tukey’s post-hoc multiple comparison tests (J-L). Mean±s.e.m. (C-F and I-L). See also Figures S5 .
Dreadd Actuator Dcz, supplied by Nagai Nori USA INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dreadd/dreadd+agonist+dcz/10__7554_slash_elife__80747-143-3-25
Average 90 stars, based on 1 article reviews
dreadd actuator dcz - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Enzo Biochem dreadd-hm3dq
(A) Experimental scheme showing rectal AKP transplantation into Lepr-Cre(+);Chrm3 fl/fl and control mice. IVIS, in vivo imaging. (B and C) Mouse survival (B) and tumor-derived luciferase signals (C). n=6 ( Lepr-Cre(−);Chrm3 fl/fl ) and 9 mice ( Lepr-Cre(+);Chrm3 fl/fl ). (D) Non-phosphorylated YAP/PDGFRA co-IF. Red arrowheads; non-phosphorylated (active) YAP in PDGFRA + CAFs. cKO, conditional KO. n=5 mice. (E) NTN1/PDGFRA co-IF. n=5 mice. (F) VAChT IHC. Red arrowheads; VAChT + nerves. n=5 mice. (G) Experimental scheme showing rectal AKP transplantation with daily intratumor injection of the hM3Dq agonist <t>C21</t> (0.03 mg/kg) from Day 8. (H and I) Mouse survival (H) and tumor-derived luciferase signals (I). n=8 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 fl/fl ), and 7 mice ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl ). (J) Non-phosphorylated YAP/PDGFRA co-IF. Red/purple arrowheads; non-phosphorylated YAP in PDGFRA + CAFs in the Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl groups. n=4 mice. (K) NTN1/PDGFRA co-IF. n=4 mice. (L) VAChT IHC. Green/red arrowheads:VAChT + nerves in the Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT groups. n=4 mice. Scale bars, 100 μm (A and G), 50/5 μm (main/insets; D, E, J, and K), 50 μm (F and L). Log-rank test (B and H), two-way repeated-measures ANOVA with post-hoc Sidak’s multiple comparison test at week 2 (C and I), two-tailed unpaired Student’s t-test (D-F), and two-way ANOVA followed by Tukey’s post-hoc multiple comparison tests (J-L). Mean±s.e.m. (C-F and I-L). See also Figures S5 .
Dreadd Hm3dq, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dreadd/dreadd+hm3dq/10__1523_slash_jneurosci__2042___16__2016-69-1-18
Average 90 stars, based on 1 article reviews
dreadd-hm3dq - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Nagai Nori USA INC dreadd actuator
(A) Experimental scheme showing rectal AKP transplantation into Lepr-Cre(+);Chrm3 fl/fl and control mice. IVIS, in vivo imaging. (B and C) Mouse survival (B) and tumor-derived luciferase signals (C). n=6 ( Lepr-Cre(−);Chrm3 fl/fl ) and 9 mice ( Lepr-Cre(+);Chrm3 fl/fl ). (D) Non-phosphorylated YAP/PDGFRA co-IF. Red arrowheads; non-phosphorylated (active) YAP in PDGFRA + CAFs. cKO, conditional KO. n=5 mice. (E) NTN1/PDGFRA co-IF. n=5 mice. (F) VAChT IHC. Red arrowheads; VAChT + nerves. n=5 mice. (G) Experimental scheme showing rectal AKP transplantation with daily intratumor injection of the hM3Dq agonist <t>C21</t> (0.03 mg/kg) from Day 8. (H and I) Mouse survival (H) and tumor-derived luciferase signals (I). n=8 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 fl/fl ), and 7 mice ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl ). (J) Non-phosphorylated YAP/PDGFRA co-IF. Red/purple arrowheads; non-phosphorylated YAP in PDGFRA + CAFs in the Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl groups. n=4 mice. (K) NTN1/PDGFRA co-IF. n=4 mice. (L) VAChT IHC. Green/red arrowheads:VAChT + nerves in the Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT groups. n=4 mice. Scale bars, 100 μm (A and G), 50/5 μm (main/insets; D, E, J, and K), 50 μm (F and L). Log-rank test (B and H), two-way repeated-measures ANOVA with post-hoc Sidak’s multiple comparison test at week 2 (C and I), two-tailed unpaired Student’s t-test (D-F), and two-way ANOVA followed by Tukey’s post-hoc multiple comparison tests (J-L). Mean±s.e.m. (C-F and I-L). See also Figures S5 .
Dreadd Actuator, supplied by Nagai Nori USA INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dreadd/dreadd/pm34672984-32-7-10
Average 90 stars, based on 1 article reviews
dreadd actuator - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Nagai Nori USA INC non-dreadd control
(A) Experimental scheme showing rectal AKP transplantation into Lepr-Cre(+);Chrm3 fl/fl and control mice. IVIS, in vivo imaging. (B and C) Mouse survival (B) and tumor-derived luciferase signals (C). n=6 ( Lepr-Cre(−);Chrm3 fl/fl ) and 9 mice ( Lepr-Cre(+);Chrm3 fl/fl ). (D) Non-phosphorylated YAP/PDGFRA co-IF. Red arrowheads; non-phosphorylated (active) YAP in PDGFRA + CAFs. cKO, conditional KO. n=5 mice. (E) NTN1/PDGFRA co-IF. n=5 mice. (F) VAChT IHC. Red arrowheads; VAChT + nerves. n=5 mice. (G) Experimental scheme showing rectal AKP transplantation with daily intratumor injection of the hM3Dq agonist <t>C21</t> (0.03 mg/kg) from Day 8. (H and I) Mouse survival (H) and tumor-derived luciferase signals (I). n=8 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 fl/fl ), and 7 mice ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl ). (J) Non-phosphorylated YAP/PDGFRA co-IF. Red/purple arrowheads; non-phosphorylated YAP in PDGFRA + CAFs in the Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl groups. n=4 mice. (K) NTN1/PDGFRA co-IF. n=4 mice. (L) VAChT IHC. Green/red arrowheads:VAChT + nerves in the Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT groups. n=4 mice. Scale bars, 100 μm (A and G), 50/5 μm (main/insets; D, E, J, and K), 50 μm (F and L). Log-rank test (B and H), two-way repeated-measures ANOVA with post-hoc Sidak’s multiple comparison test at week 2 (C and I), two-tailed unpaired Student’s t-test (D-F), and two-way ANOVA followed by Tukey’s post-hoc multiple comparison tests (J-L). Mean±s.e.m. (C-F and I-L). See also Figures S5 .
Non Dreadd Control, supplied by Nagai Nori USA INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dreadd/non+dreadd+control/10__1523_slash_jneurosci__1657___21__2021-91-36-46
Average 90 stars, based on 1 article reviews
non-dreadd control - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Nagai Nori USA INC dredd-selective radioligand 11c-labeled dcz
(A) Experimental scheme showing rectal AKP transplantation into Lepr-Cre(+);Chrm3 fl/fl and control mice. IVIS, in vivo imaging. (B and C) Mouse survival (B) and tumor-derived luciferase signals (C). n=6 ( Lepr-Cre(−);Chrm3 fl/fl ) and 9 mice ( Lepr-Cre(+);Chrm3 fl/fl ). (D) Non-phosphorylated YAP/PDGFRA co-IF. Red arrowheads; non-phosphorylated (active) YAP in PDGFRA + CAFs. cKO, conditional KO. n=5 mice. (E) NTN1/PDGFRA co-IF. n=5 mice. (F) VAChT IHC. Red arrowheads; VAChT + nerves. n=5 mice. (G) Experimental scheme showing rectal AKP transplantation with daily intratumor injection of the hM3Dq agonist <t>C21</t> (0.03 mg/kg) from Day 8. (H and I) Mouse survival (H) and tumor-derived luciferase signals (I). n=8 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 fl/fl ), and 7 mice ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl ). (J) Non-phosphorylated YAP/PDGFRA co-IF. Red/purple arrowheads; non-phosphorylated YAP in PDGFRA + CAFs in the Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl groups. n=4 mice. (K) NTN1/PDGFRA co-IF. n=4 mice. (L) VAChT IHC. Green/red arrowheads:VAChT + nerves in the Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT groups. n=4 mice. Scale bars, 100 μm (A and G), 50/5 μm (main/insets; D, E, J, and K), 50 μm (F and L). Log-rank test (B and H), two-way repeated-measures ANOVA with post-hoc Sidak’s multiple comparison test at week 2 (C and I), two-tailed unpaired Student’s t-test (D-F), and two-way ANOVA followed by Tukey’s post-hoc multiple comparison tests (J-L). Mean±s.e.m. (C-F and I-L). See also Figures S5 .
Dredd Selective Radioligand 11c Labeled Dcz, supplied by Nagai Nori USA INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dreadd/dreadd+selective+probe+11clabeled+deschloroclozapine++dcz+/10__1523_slash_jneurosci__0229___22__2022-110-19-23
Average 90 stars, based on 1 article reviews
dredd-selective radioligand 11c-labeled dcz - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


KEY RESOURCES TABLE

Journal: Cell reports

Article Title: AAV5-mediated manipulation of insulin expression in choroid plexus has long-term metabolic and behavioral consequences

doi: 10.1016/j.celrep.2023.112903

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: ​ REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Monoclonal Rabbbit anti-TTR (prealbumin) AbCam Cat # ab75815; RRID:AB_1310604 Monoclonal Rabbit anti-Insulin Cell Signaling Cat # 3014; RRID:AB_2126503 Polyclonal Rabbit anti-mCherry Rockland Cat # 600-401-P16; RRID:AB_2614470 Monoclonal Rabbit anti- p -Akt (Ser473) Cell Signaling Cat # 4060; RRID:AB_2315049 Monoclonal Mouse anti-Alpha1 Na+/K+ ATPase AbCam Cat # ab7671; RRID:AB_306023 Bacterial and virus strains AAV5-CMV-CRE Vector Biolabs Cat # 7012 AAV5-CMV-GFP Vector Biolabs Cat # 7006 AAV5-CMV-Ins2 Vector Biolabs Cat # AAV-262269 AAV5-CMV-GCaMP6f Vector Biolabs Built to order AAV5-TTR-hM3Dq-mCherry Vector Biolabs Built to order AAV5-CMV-Psck1 Vector Biolabs Cat # AAV-268239 AAV5-CMV-Pcsk2 Vector Biolabs Cat # AAV-268242 Chemicals, peptides, and recombinant proteins Compound 21 TOCRIS Cat # 5548 Critical commercial assays PicoPure RNA Isolation Kit ThermoFisher Cat # KIT0204 Ultra Sensitive Insulin ELISA Kit CrystalChem Cat # 90080 Deposited data Raw and analyzed data of RNA-seq This paper GEO: GSE218188 Experimental models: Cell lines iPS(IMR90)-4 WiCell WISCi004-B Experimental models: Organisms/strains C57BL/6J The Jackson Laboratory Strain # 000664 Ai14 The Jackson Laboratory Strain #007914 Ins1 −/− Ins2 fl/fl This paper N/A Software and algorithms ImageJ NIH https://imagej.nih.gov/ij/ GraphPad Prism GraphPad https://graphpad.com R R Foundation for Statistical Computing https://www.r-project.org Other Normal chow diet Dyets Inc Cat# 101845 High fat/high sugar diet Dyets Inc Cat# 103806 Open in a separate window KEY RESOURCES TABLE.

Techniques: Virus, Plasmid Preparation, Recombinant, Isolation, Enzyme-linked Immunosorbent Assay, Software

(A) Experimental scheme showing rectal AKP transplantation into Lepr-Cre(+);Chrm3 fl/fl and control mice. IVIS, in vivo imaging. (B and C) Mouse survival (B) and tumor-derived luciferase signals (C). n=6 ( Lepr-Cre(−);Chrm3 fl/fl ) and 9 mice ( Lepr-Cre(+);Chrm3 fl/fl ). (D) Non-phosphorylated YAP/PDGFRA co-IF. Red arrowheads; non-phosphorylated (active) YAP in PDGFRA + CAFs. cKO, conditional KO. n=5 mice. (E) NTN1/PDGFRA co-IF. n=5 mice. (F) VAChT IHC. Red arrowheads; VAChT + nerves. n=5 mice. (G) Experimental scheme showing rectal AKP transplantation with daily intratumor injection of the hM3Dq agonist C21 (0.03 mg/kg) from Day 8. (H and I) Mouse survival (H) and tumor-derived luciferase signals (I). n=8 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 fl/fl ), and 7 mice ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl ). (J) Non-phosphorylated YAP/PDGFRA co-IF. Red/purple arrowheads; non-phosphorylated YAP in PDGFRA + CAFs in the Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl groups. n=4 mice. (K) NTN1/PDGFRA co-IF. n=4 mice. (L) VAChT IHC. Green/red arrowheads:VAChT + nerves in the Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT groups. n=4 mice. Scale bars, 100 μm (A and G), 50/5 μm (main/insets; D, E, J, and K), 50 μm (F and L). Log-rank test (B and H), two-way repeated-measures ANOVA with post-hoc Sidak’s multiple comparison test at week 2 (C and I), two-tailed unpaired Student’s t-test (D-F), and two-way ANOVA followed by Tukey’s post-hoc multiple comparison tests (J-L). Mean±s.e.m. (C-F and I-L). See also Figures S5 .

Journal: Cancer cell

Article Title: Cholinergic signaling via muscarinic receptor 3 promotes colorectal cancer progression directly and indirectly through stroma-derived Netrin-1

doi: 10.1016/j.ccell.2026.06.018

Figure Lengend Snippet: (A) Experimental scheme showing rectal AKP transplantation into Lepr-Cre(+);Chrm3 fl/fl and control mice. IVIS, in vivo imaging. (B and C) Mouse survival (B) and tumor-derived luciferase signals (C). n=6 ( Lepr-Cre(−);Chrm3 fl/fl ) and 9 mice ( Lepr-Cre(+);Chrm3 fl/fl ). (D) Non-phosphorylated YAP/PDGFRA co-IF. Red arrowheads; non-phosphorylated (active) YAP in PDGFRA + CAFs. cKO, conditional KO. n=5 mice. (E) NTN1/PDGFRA co-IF. n=5 mice. (F) VAChT IHC. Red arrowheads; VAChT + nerves. n=5 mice. (G) Experimental scheme showing rectal AKP transplantation with daily intratumor injection of the hM3Dq agonist C21 (0.03 mg/kg) from Day 8. (H and I) Mouse survival (H) and tumor-derived luciferase signals (I). n=8 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT ), 7 ( Lepr-Cre;LSL-hM3Dq(−);Ntn1 fl/fl ), and 7 mice ( Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl ). (J) Non-phosphorylated YAP/PDGFRA co-IF. Red/purple arrowheads; non-phosphorylated YAP in PDGFRA + CAFs in the Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 fl/fl groups. n=4 mice. (K) NTN1/PDGFRA co-IF. n=4 mice. (L) VAChT IHC. Green/red arrowheads:VAChT + nerves in the Lepr-Cre;LSL-hM3Dq(−);Ntn1 WT / Lepr-Cre;LSL-hM3Dq(+);Ntn1 WT groups. n=4 mice. Scale bars, 100 μm (A and G), 50/5 μm (main/insets; D, E, J, and K), 50 μm (F and L). Log-rank test (B and H), two-way repeated-measures ANOVA with post-hoc Sidak’s multiple comparison test at week 2 (C and I), two-tailed unpaired Student’s t-test (D-F), and two-way ANOVA followed by Tukey’s post-hoc multiple comparison tests (J-L). Mean±s.e.m. (C-F and I-L). See also Figures S5 .

Article Snippet: A Hamilton syringe holding a 33-gauge needle was used to inject C21 (0.03 mg/kg; HY-100234A, MedChemExpress; a volume of 10 μL, dissolved in DPBS) into the rectal tumor percutaneously through the anal skin.

Techniques: Expressing, Transplantation Assay, Control, In Vivo Imaging, Derivative Assay, Luciferase, Injection, Comparison, Two Tailed Test, Immunohistochemistry

(A) Luciferase (luc)-expressing AKP tumor organoids were co-treated with ACh and an AChR antagonist for 72 h. AKP tumor-derived luc signals were measured as a surrogate for viable cell numbers. Drug concentration as in Figure 2A . n=4. (B) Luc signals from control gRNA/g Chrm3 -expressing luc + AKP organoids treated (72 h). Bethanechol (Beth), 10 μM. n=4. (C) Gene set enrichment analysis of the YAP gene signature 53 using bulk RNA-seq from Beth-/vehicle-treated AKP organoids. The normalized enrichment score (NES) and false discovery rate (FDR)-adjusted P value are shown. n=3. (D) Western blotting of control gRNA/g Chrm3 -expressing AKP tumor cells treated (20 min). Red dotted rectangles: dephosphorylation of LATS1/YAP by ACh/Beth treatment. FR900359 (FR, Gq inhibitor), 1 μM. (E) Luc signals from luc + AKP organoids treated (72 h). VP, verteporfin (YAP inhibitor, 0.5 μM). n=5. (F) Experimental scheme showing rectal AKP transplantation with daily intratumor injection of the hM3Dq agonist C21 (0.03 mg/kg) from Day 8. (G and H) Mouse survival (G) and tumor-derived luc signals (H). n=10 ( Chat-Cre(−);hM3Dq mice; control AKP), 9 ( Chat-Cre(+);hM3Dq mice; control AKP), 9 ( Chat-Cre(−);hM3Dq mice; g Chrm3 AKP), and 9 mice ( Chat-Cre(+);hM3Dq mice; g Chrm3 AKP). (I) Non-phosphorylated YAP/luc (a marker for luc + AKP cancer cells) co-IF. Red arrowheads; non-phosphorylated YAP in luc + cancer cells. n=5 mice. Scale bars, 100 μm (A and F) and 50/5 μm (main/insets; I). One-way ANOVA followed by Tukey’s post-hoc multiple comparison tests (A, B, and E), gene set permutation tests (C), log-rank test (G), two-way repeated-measures ANOVA with post-hoc Sidak’s multiple comparison test at week 2 (H), and two-way ANOVA followed by Tukey’s post-hoc multiple comparison tests (I). Mean±s.e.m. (A, B, E, H, and I). See also Figures S6 and S7 ; Tables S3 and S4 .

Journal: Cancer cell

Article Title: Cholinergic signaling via muscarinic receptor 3 promotes colorectal cancer progression directly and indirectly through stroma-derived Netrin-1

doi: 10.1016/j.ccell.2026.06.018

Figure Lengend Snippet: (A) Luciferase (luc)-expressing AKP tumor organoids were co-treated with ACh and an AChR antagonist for 72 h. AKP tumor-derived luc signals were measured as a surrogate for viable cell numbers. Drug concentration as in Figure 2A . n=4. (B) Luc signals from control gRNA/g Chrm3 -expressing luc + AKP organoids treated (72 h). Bethanechol (Beth), 10 μM. n=4. (C) Gene set enrichment analysis of the YAP gene signature 53 using bulk RNA-seq from Beth-/vehicle-treated AKP organoids. The normalized enrichment score (NES) and false discovery rate (FDR)-adjusted P value are shown. n=3. (D) Western blotting of control gRNA/g Chrm3 -expressing AKP tumor cells treated (20 min). Red dotted rectangles: dephosphorylation of LATS1/YAP by ACh/Beth treatment. FR900359 (FR, Gq inhibitor), 1 μM. (E) Luc signals from luc + AKP organoids treated (72 h). VP, verteporfin (YAP inhibitor, 0.5 μM). n=5. (F) Experimental scheme showing rectal AKP transplantation with daily intratumor injection of the hM3Dq agonist C21 (0.03 mg/kg) from Day 8. (G and H) Mouse survival (G) and tumor-derived luc signals (H). n=10 ( Chat-Cre(−);hM3Dq mice; control AKP), 9 ( Chat-Cre(+);hM3Dq mice; control AKP), 9 ( Chat-Cre(−);hM3Dq mice; g Chrm3 AKP), and 9 mice ( Chat-Cre(+);hM3Dq mice; g Chrm3 AKP). (I) Non-phosphorylated YAP/luc (a marker for luc + AKP cancer cells) co-IF. Red arrowheads; non-phosphorylated YAP in luc + cancer cells. n=5 mice. Scale bars, 100 μm (A and F) and 50/5 μm (main/insets; I). One-way ANOVA followed by Tukey’s post-hoc multiple comparison tests (A, B, and E), gene set permutation tests (C), log-rank test (G), two-way repeated-measures ANOVA with post-hoc Sidak’s multiple comparison test at week 2 (H), and two-way ANOVA followed by Tukey’s post-hoc multiple comparison tests (I). Mean±s.e.m. (A, B, E, H, and I). See also Figures S6 and S7 ; Tables S3 and S4 .

Article Snippet: A Hamilton syringe holding a 33-gauge needle was used to inject C21 (0.03 mg/kg; HY-100234A, MedChemExpress; a volume of 10 μL, dissolved in DPBS) into the rectal tumor percutaneously through the anal skin.

Techniques: Activation Assay, Luciferase, Expressing, Organoids, Derivative Assay, Concentration Assay, Control, Analysis, RNA Sequencing, Western Blot, De-Phosphorylation Assay, Transplantation Assay, Injection, Marker, Comparison